Fleury S.A. (BVMF:FLRY3)
14.05
+0.08 (0.57%)
Aug 14, 2025, 4:45 PM GMT-3
Fleury Company Description
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil.
It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services.
In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers.
Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
Fleury S.A.

Country | Brazil |
Founded | 1926 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 27,500 |
CEO | Jeane Tsutsui |
Contact Details
Address: Avenida Morumbi São Paulo, 04703-003 Brazil | |
Phone | 55 11 5014 7236 |
Website | ri.fleury.com.br |
Stock Details
Ticker Symbol | FLRY3 |
Exchange | Brazil Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | BRL |
ISIN Number | BRFLRYACNOR5 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jeane Mike Tsutsui | Chief Executive Officer and President of Executive Board |
Jose Antonio de Almeida Filippo | Chief Financial Officer, Investor Relations Officer and Member of Executive Board |
Claudio Almeida Prado | Executive Director of New Links and Member of Executive Board |
Edgar Gil Rizzatti | Medical, Technical and Process Executive Director and Member of Executive Board |
Roberto Santoro Meirelles | L2L and Operations Support Officer and Member of Executive Board |
Angelica Dente de Menezes | Secretary |